Amphastar Pharmaceuticals, Inc. (AMPH)
29.37
+0.50
(+1.73%)
USD |
NASDAQ |
Nov 13, 16:00
29.38
0.00 (0.00%)
After-Hours: 19:59
Amphastar Pharmaceuticals Market Cap : 1.253B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.253B |
| November 12, 2026 | 1.231B |
| November 11, 2026 | 1.220B |
| November 10, 2026 | 1.239B |
| November 09, 2026 | 1.253B |
| November 06, 2026 | 1.215B |
| November 05, 2026 | 1.180B |
| November 04, 2026 | 1.195B |
| November 03, 2026 | 1.157B |
| November 02, 2026 | 1.150B |
| October 30, 2026 | 1.179B |
| October 29, 2026 | 1.145B |
| October 28, 2026 | 1.120B |
| October 27, 2026 | 1.088B |
| October 26, 2026 | 1.083B |
| October 23, 2026 | 1.069B |
| October 22, 2026 | 1.108B |
| October 21, 2026 | 1.114B |
| October 20, 2026 | 1.103B |
| October 19, 2026 | 1.112B |
| October 16, 2026 | 1.100B |
| October 15, 2026 | 1.124B |
| October 14, 2026 | 1.109B |
| October 13, 2026 | 1.108B |
| October 12, 2026 | 1.138B |
| Date | Value |
|---|---|
| October 09, 2026 | 1.132B |
| October 08, 2026 | 1.098B |
| October 07, 2026 | 1.086B |
| October 06, 2026 | 1.102B |
| October 05, 2026 | 1.079B |
| October 02, 2026 | 1.082B |
| October 01, 2026 | 1.078B |
| September 30, 2026 | 1.098B |
| September 29, 2026 | 1.135B |
| September 28, 2026 | 1.165B |
| September 25, 2026 | 1.111B |
| September 24, 2026 | 1.117B |
| September 23, 2026 | 1.062B |
| September 22, 2026 | 1.034B |
| September 21, 2026 | 1.041B |
| September 18, 2026 | 1.005B |
| September 17, 2026 | 1.013B |
| September 16, 2026 | 1.019B |
| September 15, 2026 | 1.005B |
| September 14, 2026 | 1.017B |
| September 11, 2026 | 1.011B |
| September 10, 2026 | 1.001B |
| September 09, 2026 | 979.94M |
| September 08, 2026 | 975.26M |
| September 04, 2026 | 985.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viatris, Inc. | 23.87B |
| Johnson & Johnson | 687.83B |
| Eli Lilly & Co. | 1.359T |
| Merck & Co., Inc. | 364.49B |
| Pfizer Inc. | 164.67B |
Market Cap Related Metrics
| PE Ratio | 13.27 |
| PS Ratio | 1.784 |
| Price to Book Value | 1.538 |
| Price to Free Cash Flow | 29.89 |
| Price | 29.37 |
| Earnings Yield | 7.53% |
| Operating PE Ratio | 9.522 |
| Normalized PE Ratio | 14.92 |